BlackRock Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $100M | Sell |
2,761,360
-73,804
| -3% | -$2.68M | 0.12% | 170 |
|
|
2016
Q3 | $130M | Sell |
2,835,164
-638,394
| -18% | -$29.4M | 0.16% | 135 |
|
|
2016
Q2 | $174M | Sell |
3,473,558
-18,029
| -0.5% | -$906K | 0.22% | 98 |
|
|
2016
Q1 | $187M | Sell |
3,491,587
-219,368
| -6% | -$11.7M | 0.24% | 87 |
|
|
2015
Q4 | $244M | Buy |
3,710,955
+116,913
| +3% | +$7.67M | 0.31% | 71 |
|
|
2015
Q3 | $203M | Sell |
3,594,042
-846,614
| -19% | -$47.8M | 0.27% | 83 |
|
|
2015
Q2 | $262M | Buy |
4,440,656
+45,321
| +1% | +$2.68M | 0.33% | 64 |
|
|
2015
Q1 | $274M | Buy |
4,395,335
+1,276,153
| +41% | +$79.5M | 0.36% | 59 |
|
|
2014
Q4 | $179M | Buy |
3,119,182
+474,886
| +18% | +$27.3M | 0.24% | 93 |
|
|
2014
Q3 | $142M | Buy |
2,644,296
+1,114,323
| +73% | +$59.9M | 0.2% | 114 |
|
|
2014
Q2 | $80.2M | Buy |
1,529,973
+315,228
| +26% | +$16.5M | 0.11% | 189 |
|
|
2014
Q1 | $64.2M | Buy |
1,214,745
+530,747
| +78% | +$28M | 0.09% | 207 |
|
|
2013
Q4 | $27.4M | Buy |
683,998
+246,398
| +56% | +$9.88M | 0.04% | 393 |
|
|
2013
Q3 | $16.5M | Buy |
437,600
+67,386
| +18% | +$2.55M | 0.03% | 543 |
|
|
2013
Q2 | $14.5M | Buy |
+370,214
| New | +$14.5M | 0.03% | 550 |
|